BAX2398

· Institut de Recherches Internationales Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAX2398, covering 2024-07-25 to 2024-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer [Phase 2]